XVIVO delivers a Q3 that aligns with our expectations but is below market expectations due to FX headwind. The increased disposable capacity contributed to 54% growth of Thoracic disposables (62% for the whole Thoracic business based on CER), the service offer is subject to improvements, and Abdominal disposables had a modest quarter at 13% organic growth. On the positive side, we note that machine sales are high, so we are suggesting additional support in the future. The organic growth (CER) was 41%, which is a positive surprise even if actual sales were below market expectations and the FX headwind was higher than expected at 6% vs the expected -2%.
LÄS MER